JAK2 and breast cancer: While the role of PRL in breast cancer has yet to be fully defined, PRL and its signaling pathway Jak2/Stat5 were shown to stabilize cell adhesion complexes and suppress the EMT process and invasive properties of breast cancer cells [13,14,15].